BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25696850)

  • 1. Indolent lymphoma: follicular lymphoma and the microenvironment-insights from gene expression profiling.
    Rimsza LM; Jaramillo MC
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):163-8. PubMed ID: 25696850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.
    Glas AM; Knoops L; Delahaye L; Kersten MJ; Kibbelaar RE; Wessels LA; van Laar R; van Krieken JH; Baars JW; Raemaekers J; Kluin PM; van't Veer LJ; de Jong D
    J Clin Oncol; 2007 Feb; 25(4):390-8. PubMed ID: 17200149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor microenvironment in follicular lymphoma.
    Yang ZZ; Ansell SM
    Clin Adv Hematol Oncol; 2012 Dec; 10(12):810-8. PubMed ID: 23271353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transducers and activators of transcription 5a-dependent cross-talk between follicular lymphoma cells and tumor microenvironment characterizes a group of patients with improved outcome after R-CHOP.
    Taskinen M; Valo E; Karjalainen-Lindsberg ML; Hautaniemi S; Meri S; Leppä S
    Clin Cancer Res; 2010 May; 16(9):2615-23. PubMed ID: 20388848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indolent lymphoma: follicular lymphoma and the microenvironment-insights from the microscope.
    Harris NL
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):158-62. PubMed ID: 25696849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
    Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
    APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The yin and the yang of follicular lymphoma cell niches: role of microenvironment heterogeneity and plasticity.
    Amé-Thomas P; Tarte K
    Semin Cancer Biol; 2014 Feb; 24():23-32. PubMed ID: 23978491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the multi-omics landscape of follicular lymphoma.
    Xu T; Zheng Z; Zhao W
    Int J Biol Sci; 2023; 19(6):1955-1967. PubMed ID: 37063433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular Lymphoma: The Role of the Tumor Microenvironment in Prognosis.
    Sugimoto T; Watanabe T
    J Clin Exp Hematop; 2016; 56(1):1-19. PubMed ID: 27334853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressors in follicular lymphoma.
    Graham C; LeBrun DP
    Leuk Lymphoma; 2015 Jul; 56(7):1981-8. PubMed ID: 25379618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation.
    Kiaii S; Clear AJ; Ramsay AG; Davies D; Sangaralingam A; Lee A; Calaminici M; Neuberg DS; Gribben JG
    J Clin Oncol; 2013 Jul; 31(21):2654-61. PubMed ID: 23775959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformed follicular lymphoma.
    Fischer T; Zing NPC; Chiattone CS; Federico M; Luminari S
    Ann Hematol; 2018 Jan; 97(1):17-29. PubMed ID: 29043381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors.
    de Jong D
    J Clin Oncol; 2005 Sep; 23(26):6358-63. PubMed ID: 16155020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling.
    Josefsson SE; Huse K; Kolstad A; Beiske K; Pende D; Steen CB; Inderberg EM; Lingjærde OC; Østenstad B; Smeland EB; Levy R; Irish JM; Myklebust JH
    Clin Cancer Res; 2018 Feb; 24(4):870-881. PubMed ID: 29217528
    [No Abstract]   [Full Text] [Related]  

  • 15. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs.
    Devan J; Janikova A; Mraz M
    Semin Oncol; 2018 Oct; 45(5-6):291-302. PubMed ID: 30360879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of follicular lymphoma to plasmablastic lymphoma with c-myc gene rearrangement.
    Ouansafi I; He B; Fraser C; Nie K; Mathew S; Bhanji R; Hoda R; Arabadjief M; Knowles D; Cerutti A; Orazi A; Tam W
    Am J Clin Pathol; 2010 Dec; 134(6):972-81. PubMed ID: 21088162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
    Goy A; Stewart J; Barkoh BA; Remache YK; Katz R; Sneige N; Gilles F
    Cancer; 2006 Feb; 108(1):10-20. PubMed ID: 16329118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology, pathogenesis and molecular genetics of follicular NHL.
    Leich E; Ott G; Rosenwald A
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):95-109. PubMed ID: 21658611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling in follicular lymphoma and its implication for clinical practice.
    Janikova A; Tichy B; Supikova J; Stano-Kozubik K; Pospisilova S; Kren L; Vasova I; Salek D; Mayer J
    Leuk Lymphoma; 2011 Jan; 52(1):59-68. PubMed ID: 21133732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microenvironment in follicular lymphoma.
    de Jong D; Fest T
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):135-46. PubMed ID: 21658614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.